BR0109740A - Método para produção de igg a partir de plasma para aplicações médicas - Google Patents
Método para produção de igg a partir de plasma para aplicações médicasInfo
- Publication number
- BR0109740A BR0109740A BR0109740-7A BR0109740A BR0109740A BR 0109740 A BR0109740 A BR 0109740A BR 0109740 A BR0109740 A BR 0109740A BR 0109740 A BR0109740 A BR 0109740A
- Authority
- BR
- Brazil
- Prior art keywords
- igg
- igg fraction
- plasma
- iii
- medical applications
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 241000700605 Viruses Species 0.000 abstract 2
- 150000001768 cations Chemical class 0.000 abstract 2
- 230000002779 inactivation Effects 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 102000009027 Albumins Human genes 0.000 abstract 1
- 108010088751 Albumins Proteins 0.000 abstract 1
- 108060003951 Immunoglobulin Proteins 0.000 abstract 1
- 230000003171 anti-complementary effect Effects 0.000 abstract 1
- 102000018358 immunoglobulin Human genes 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
- C07K16/065—Purification, fragmentation
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0001128A SE0001128D0 (sv) | 2000-03-30 | 2000-03-30 | A method of producing IgG |
SE0001128-8 | 2000-03-30 | ||
PCT/EP2001/003624 WO2001072844A2 (en) | 2000-03-30 | 2001-03-29 | A METHOD OF PRODUCING IgG |
Publications (3)
Publication Number | Publication Date |
---|---|
BR0109740A true BR0109740A (pt) | 2003-02-04 |
BR0109740B1 BR0109740B1 (pt) | 2015-01-06 |
BRPI0109740B8 BRPI0109740B8 (pt) | 2021-05-25 |
Family
ID=20279068
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0109740A BRPI0109740B8 (pt) | 2000-03-30 | 2001-03-29 | método para produção de igg a partir de plasma para aplicações médicas |
Country Status (15)
Country | Link |
---|---|
US (1) | US6835379B2 (pt) |
EP (1) | EP1268551B1 (pt) |
JP (1) | JP2003530326A (pt) |
CN (1) | CN1419566A (pt) |
AT (1) | ATE260297T1 (pt) |
AU (2) | AU2001273907B2 (pt) |
BR (1) | BRPI0109740B8 (pt) |
CA (1) | CA2402784A1 (pt) |
DE (1) | DE60102144T2 (pt) |
IL (1) | IL151667A0 (pt) |
PT (1) | PT1268551E (pt) |
RU (1) | RU2266914C2 (pt) |
SE (1) | SE0001128D0 (pt) |
TR (1) | TR200400701T4 (pt) |
WO (1) | WO2001072844A2 (pt) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE540050T1 (de) * | 2003-09-05 | 2012-01-15 | Toray Industries | Verfahren zur herstellung einer proteomanalyse- lösung |
CN100451031C (zh) * | 2003-09-05 | 2009-01-14 | 东丽株式会社 | 生物体成分组成改变了的溶液的调制方法 |
EP1532983A1 (en) | 2003-11-18 | 2005-05-25 | ZLB Bioplasma AG | Immunoglobulin preparations having increased stability |
TWI391399B (zh) | 2005-05-25 | 2013-04-01 | Hoffmann La Roche | 測定溶離多肽之鹽濃度之方法 |
US8293242B2 (en) * | 2005-09-01 | 2012-10-23 | Plasma Technologies, Llc | Ultra-high yield of alpha-1-anti-trypsin |
US7879332B2 (en) * | 2005-09-01 | 2011-02-01 | Plasma Technologies, Llc | Ultra-high yield intravenous immune globulin preparation |
US20070049732A1 (en) * | 2005-09-01 | 2007-03-01 | Zurlo Eugene J | Ultra-high yield intravenous immune globulin preparation |
CN100362022C (zh) * | 2005-11-07 | 2008-01-16 | 中国人民解放军第二军医大学 | 海螵蛸多糖cps-1及其制备方法和用途 |
US20070128693A1 (en) * | 2005-12-06 | 2007-06-07 | Advantek Serum Laboratories Limited3/F | Method for the inactivation and removal of dengue virus from biological samples |
WO2007136327A1 (en) * | 2006-05-22 | 2007-11-29 | Ge Healthcare Bio-Sciences Ab | A method of producing igg |
US20100158893A1 (en) * | 2008-12-19 | 2010-06-24 | Baxter International Inc. | Systems and methods for obtaining immunoglobulin from blood |
SG176256A1 (en) | 2009-05-27 | 2012-01-30 | Baxter Int | A method to produce a highly concentrated immunoglobulin preparation for subcutaneous use |
EP4328305A3 (en) | 2009-12-18 | 2024-08-14 | CSL Ltd. | Method of purifying polypeptides |
EP2519537A4 (en) * | 2009-12-29 | 2013-07-10 | Reddys Lab Ltd Dr | CLEANING PROTEINS |
AU2011212440B2 (en) | 2010-02-04 | 2015-01-22 | Csl Behring Ag | Immunoglobulin preparation |
EP2361636A1 (en) | 2010-02-26 | 2011-08-31 | CSL Behring AG | Immunoglobulin preparation and storage system for an immunoglobulin preparation |
US8796430B2 (en) | 2010-05-26 | 2014-08-05 | Baxter International Inc. | Method to produce an immunoglobulin preparation with improved yield |
US8772462B2 (en) | 2010-05-26 | 2014-07-08 | Baxter International Inc. | Removal of serine proteases by treatment with finely divided silicon dioxide |
AU2010202125B1 (en) | 2010-05-26 | 2010-09-02 | Takeda Pharmaceutical Company Limited | A method to produce an immunoglobulin preparation with improved yield |
AR087953A1 (es) * | 2011-08-26 | 2014-04-30 | Baxter Int | Metodo para reducir el potencial tromboembolico de una composicion de inmunoglobulina derivada de plasma |
TWI629283B (zh) | 2012-02-23 | 2018-07-11 | 巴克斯歐塔公司 | 來自血漿中的免疫球蛋白之i-iv-1部分沉澱 |
CN110343171A (zh) | 2012-02-29 | 2019-10-18 | 百深公司 | 周围神经的IgG刺激髓鞘再生 |
AU2013203043B2 (en) * | 2013-03-15 | 2016-10-06 | Takeda Pharmaceutical Company Limited | Methods to produce a human plasma-derived igg preparation enriched in brain disease-related natural iggs |
FR3018450B1 (fr) * | 2014-03-11 | 2016-04-15 | Lab Francais Du Fractionnement | Procede de preparation de proteines plasmatiques humaines |
CN104231065A (zh) * | 2014-09-09 | 2014-12-24 | 青岛康大食品有限公司 | 兔血中球蛋白的纯化制备方法 |
EP3362464B1 (en) | 2015-10-15 | 2021-04-28 | Plasma Technologies LLC | Methods for extracting proteins from blood plasma |
MX2018009331A (es) * | 2016-02-03 | 2018-11-09 | Plasma Tech Llc | Metodos para extraer proteinas a partir de un material a base de sangre. |
US10815270B1 (en) * | 2019-09-20 | 2020-10-27 | Plasma Technologies, Llc | Compositions and methods for high efficiency protein precipitation |
US10836790B1 (en) * | 2019-09-20 | 2020-11-17 | Plasma Technologies, Llc | Therapeutic protein compositions and methods |
EP4126930A1 (en) | 2020-03-31 | 2023-02-08 | Takeda Pharmaceutical Company Limited | A method to produce an immunoglobulin preparation from c-1 inhibitor depleted plasma |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3927111C3 (de) | 1989-08-17 | 1994-09-01 | Biotest Pharma Gmbh | Verfahren zur Herstellung nicht modifizierter intravenös verabreichbarer IgM- und/oderIgA-haltiger Immunglobulinpräparate |
ATE122054T1 (de) | 1990-03-22 | 1995-05-15 | Biotest Pharma Gmbh | Verfahren zur herstellung eines intravenös verträglichen immunglobulin-g-präparates. |
DE4118912C1 (pt) * | 1991-06-08 | 1992-07-02 | Biotest Pharma Gmbh, 6072 Dreieich, De | |
EP0659767B2 (de) * | 1993-12-27 | 2002-11-06 | ZLB Bioplasma AG | Verfahren zur Herstellung eines Konzentrates von Anti-D-Immunoglobulin G und pharmazeutische Zusammensetzung, die dieses enthält |
US5429746A (en) * | 1994-02-22 | 1995-07-04 | Smith Kline Beecham Corporation | Antibody purification |
US5886154A (en) * | 1997-06-20 | 1999-03-23 | Lebing; Wytold R. | Chromatographic method for high yield purification and viral inactivation of antibodies |
IL121900A (en) | 1997-10-07 | 2001-12-23 | Omrix Biopharmaceuticals Ltd | A method for the purification of immunoglobulins |
AU753468B2 (en) | 1998-06-09 | 2002-10-17 | Csl Behring Ag | Process for producing immunoglobulins for intravenous administration and other immunoglobulin products |
ES2527915T3 (es) * | 1998-06-09 | 2015-02-02 | Csl Behring Ag | Producto de inmunoglobulina G (IgG) líquido |
DE19923027C2 (de) * | 1999-05-19 | 2002-09-19 | Aventis Behring Gmbh | Verfahren zur Inaktivierung von Viren |
-
2000
- 2000-03-30 SE SE0001128A patent/SE0001128D0/xx unknown
-
2001
- 2001-03-29 WO PCT/EP2001/003624 patent/WO2001072844A2/en active IP Right Grant
- 2001-03-29 CN CN01807338A patent/CN1419566A/zh active Pending
- 2001-03-29 AT AT01940271T patent/ATE260297T1/de not_active IP Right Cessation
- 2001-03-29 DE DE60102144T patent/DE60102144T2/de not_active Expired - Fee Related
- 2001-03-29 TR TR2004/00701T patent/TR200400701T4/xx unknown
- 2001-03-29 BR BRPI0109740A patent/BRPI0109740B8/pt not_active IP Right Cessation
- 2001-03-29 EP EP20010940271 patent/EP1268551B1/en not_active Expired - Lifetime
- 2001-03-29 CA CA002402784A patent/CA2402784A1/en not_active Abandoned
- 2001-03-29 JP JP2001571775A patent/JP2003530326A/ja active Pending
- 2001-03-29 PT PT01940271T patent/PT1268551E/pt unknown
- 2001-03-29 AU AU2001273907A patent/AU2001273907B2/en not_active Ceased
- 2001-03-29 US US10/220,929 patent/US6835379B2/en not_active Expired - Lifetime
- 2001-03-29 RU RU2002124857/04A patent/RU2266914C2/ru not_active IP Right Cessation
- 2001-03-29 IL IL15166701A patent/IL151667A0/xx not_active IP Right Cessation
- 2001-04-02 AU AU7390701A patent/AU7390701A/xx active Pending
Also Published As
Publication number | Publication date |
---|---|
EP1268551A2 (en) | 2003-01-02 |
AU2001273907B2 (en) | 2006-02-02 |
DE60102144D1 (de) | 2004-04-01 |
DE60102144T2 (de) | 2004-10-28 |
IL151667A0 (en) | 2003-04-10 |
EP1268551B1 (en) | 2004-02-25 |
WO2001072844A2 (en) | 2001-10-04 |
US20030143222A1 (en) | 2003-07-31 |
TR200400701T4 (tr) | 2004-05-21 |
AU7390701A (en) | 2001-10-08 |
PT1268551E (pt) | 2004-07-30 |
CN1419566A (zh) | 2003-05-21 |
WO2001072844A3 (en) | 2002-04-11 |
RU2002124857A (ru) | 2004-02-20 |
SE0001128D0 (sv) | 2000-03-30 |
CA2402784A1 (en) | 2001-10-04 |
BR0109740B1 (pt) | 2015-01-06 |
ATE260297T1 (de) | 2004-03-15 |
US6835379B2 (en) | 2004-12-28 |
JP2003530326A (ja) | 2003-10-14 |
RU2266914C2 (ru) | 2005-12-27 |
BRPI0109740B8 (pt) | 2021-05-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0109740A (pt) | Método para produção de igg a partir de plasma para aplicações médicas | |
JPH0231689A (ja) | 百日咳トキシンの精製法 | |
TW245768B (en) | Method for killing microorganisms | |
DE69934269D1 (de) | Verfahren zur Reinigung und Isolierung von Viren, aus Pflanzenquellen | |
CA2557229A1 (en) | A method of providing a purified, virus safe antibody preparation | |
JP2013500711A5 (pt) | ||
PT848752E (pt) | Processo de purificacao de virus por cromatografia | |
JPS5944320A (ja) | C1不活性化剤の調製方法 | |
KR102382662B1 (ko) | 방법 | |
CA2796409A1 (en) | Process for preparing an immunoglobulin composition | |
US6893639B2 (en) | Method for high yield purification of immune globulins from blood plasma and blood plasma intermediates | |
CA2244095A1 (en) | Method of manufacturing catalyst for purifying exhaust gas | |
BR0007782A (pt) | Processo para purificar ácido hialurÈnico de alto peso molecular | |
WO2006064373A3 (en) | Methods of purifying immunologlobulins | |
JP2579217B2 (ja) | 凝固因子▲ii▼、▲vii▼、▲ix▼およびxの1または2以上を濃縮する方法 | |
WO2004015144A3 (en) | Juice purification system | |
EP1376021A4 (en) | AIR ENHANCEMENT SYSTEM, METHOD FOR DISINFECTING AIR AND METHOD AND DEVICE FOR TRANSFER | |
CN1089609C (zh) | 从人血浆分部分离过程产生的馏分中回收免疫球蛋白的方法 | |
ES8505820A1 (es) | Un procedimiento para producir una vacuna que previene la infeccion de hepatitis b | |
CN1181782A (zh) | 一种从生物原料中制备因子ix的方法 | |
AT381026B (de) | Verfahren zur herstellung einer nebenwirkungsfreien igg-immunglobulinloesung fuer die intravenoese applikation | |
TWI584810B (zh) | 缺乏一種以上致血栓因子的血漿製品之製備方法 | |
WO2005121178A3 (en) | Immunoaffinity chromatography polyol-responsive monoclonal antibodies | |
AU2003269804A1 (en) | Method of using prostacyclin to treat respiratory syncytial virus infections | |
CN1019072B (zh) | 浓缩和分离人尿中的胰蛋白酶抑制剂及胰激肽原酶的方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B25D | Requested change of name of applicant approved |
Owner name: GE HEALTHCARE BIO-SCIENCES AB (SE) Free format text: ALTERADO DE: AMERSHAM BIOSCIENCES AB |
|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 06/01/2015, OBSERVADAS AS CONDICOES LEGAIS. |
|
B25A | Requested transfer of rights approved | ||
B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 29/03/2001 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |
|
B21A | Patent or certificate of addition expired [chapter 21.1 patent gazette] |
Free format text: PATENTE EXTINTA EM 29/03/2021 |
|
B25E | Requested change of name of applicant rejected |
Free format text: INDEFERIDO O PEDIDO DE ALTERACAO DE NOME CONTIDO NA PETICAO 870210009765 DE28/01/2021 DEVIDO AO DESPACHO PUBLICADO NA RPI 2630 DE 01/06/2021. |